Colin John Meyer, Chief Innovation Officer at REATA PHARMACEUTICALS INC (RETA), sold 1,242 shares at $84.57 ($105K) on 2023-03-07, disclosed to the SEC on 2023-03-08.
Open-market sale of $105k RETA by Chief Innovation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.57 | 621 | $53K | 50.0% |
| 2 | $84.57 | 621 | $53K | 50.0% |
| Total | $84.57 avg | 1,242 | $105K | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $16.3M | — | Filing → |
| RETA | SELL | 2021-06-16 | $16.4M | — | Filing → |
| RETA | SELL | 2020-11-18 | $8.0M | — | Filing → |